H.R. 3622 · 118th Congress (2023–2025)
Cosmetic Supply Chain Transparency Act of 2023
This bill requires the Food and Drug Administration (FDA) to maintain a list of certain nonfunctional constituents in cosmetics that are harmful to human health or the environment, authorizes the FDA to request from a brand owner (i.e., the entity bringing a cosmetic to market) certain information about a cosmetic's ingredients, and addresses related issues.
For each listed nonfunctional constituent, the list must identify the ingredient or cosmetic (or category of ingredient or cosmetic) in which the constituent is known or reasonably expected to be present. The FDA must also (1) establish procedures for petitions to add substances to the list, (2) issue guidance for industry related to testing and detecting such nonfunctional constituents, and (3) establish a committee to provide advice on creating the list and developing the required industry guidance.
Within a year of a nonfunctional constituent being added to the list, a supplier of an ingredient or cosmetic must test for that constituent and provide a brand owner the results and other information before selling the ingredient or cosmetic to the brand owner. A supplier of an ingredient or cosmetic must provide additional information about the item upon a brand owner's request.
Brand owners must maintain records with information about the suppliers of ingredients and raw materials used in their cosmetics and provide such information to the FDA upon request.
The bill also imposes civil penalties for brand owners and suppliers that violate this bill's provisions.
Show official title
To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 3622’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Janice D. Schakowsky (D-IL-9)
- Cosponsors
14 cosponsors
6 original · 8 later
14 D
- Rep. Raúl M. Grijalva (D-AZ-7)· Original · May 24, 2023
- Rep. Henry C. "Hank" Johnson, Jr. (D-GA-4)· Original · May 24, 2023
- Rep. Grace Meng (D-NY-6)· Original · May 24, 2023
- Del. Eleanor Holmes Norton (D-DC)· Original · May 24, 2023
- Rep. Rashida Tlaib (D-MI-12)· Original · May 24, 2023
- Rep. Nydia M. Velázquez (D-NY-7)· Original · May 24, 2023
- Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · Jun 6, 2023
- Rep. Zoe Lofgren (D-CA-18)· Later · Jun 16, 2023
- Rep. Nikema Williams (D-GA-5)· Later · May 6, 2024
- Rep. Shontel M. Brown (D-OH-11)· Later · May 14, 2024
- Rep. Sheila Jackson Lee (D-TX-18)· Later · May 21, 2024
- Rep. Melanie A. Stansbury (D-NM-1)· Later · Jun 3, 2024
- Rep. Debbie Dingell (D-MI-6)· Later · Sep 17, 2024
- Rep. Doris O. Matsui (D-CA-7)· Later · Oct 18, 2024
- Policy area
- Health
- Subjects
- Administrative law and regulatory procedures
- Advisory bodies
- Business records
- Civil actions and liability
- Cosmetics and personal care
- Drug safety, medical device, and laboratory regulation
- Food and Drug Administration (FDA)
- Government information and archives
2 more
- Hazardous wastes and toxic substances
- Retail and wholesale trades
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · May 24, 2023 – May 26, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Cosmetic Supply Chain Transparency Act of 2023
Display title, Short title · Introduced in House
To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes.
Official title · Introduced in House